Haddad FG, Sasaki K, Issa GC, Jabbour E, et al. The presence of additional cytogenetic abnormalities (ACAs) or Philadelphia chromosome variants do not adversely affect the achievement of treatment-free remission in chronic myeloid leukemia. Am J Hematol 2024 Mar 28. doi: 10.1002/ajh.27307.
PMID: 38546372